INTRODUCTION:
Idiopathic Bell's palsy is the most common type of facial neuropathy, characterized by sudden onset of facial paresis/paralysis. It is common in adults and has equal sexual preponderance 1 . It leads to Lagophthalmos (inability to close the eyelids completely) because of paralysis of Orbicularis oculi muscle. Inability to close lids will lead to exposure of cornea, dryness and ulceration. Corneal ulceration will not heal with conventional therapy of topical antibiotic eye drops and cycloplegic eye drops. Options available to heal the ulceration of cornea are temporary taping of lids with usage of lubricating eye drops and gel ointment to protect cornea. Other option is temporary tarsorrhaphy using sutures. Permanent methods of managing Lagophthalmos like Gold plate implant in lid, Permanent tarsorrhaphy, LPS recession is not required as 85% of Bell's palsy recovers by 8-12 weeks.
Injection of Botulinum toxin A is used to create temporary ptosis which covers cornea and helps in healing exposure keratopathy 4, 5, 6 .
Aim:
Is to evaluate the efficacy of chemo-denervation of LPS to induce temporary ptosis using injection Botulinum Toxin A in protecting cornea and healing exposure keratopathy.
Materials and Methods:
This is a prospective interventional study conducted at the department of Oculoplasty and orbital disorders of Sarojini Devi eye Hospital which is tertiary eye care centre in Hyderabad. Period of study was between June 2010 to May 2012. 24 cases of proven Bell's palsy were included in the study.11 were males and13 were females. Permanent causes of facial palsy like Cerebro-pontine angle tumors, Hansen's disease, Traumatic facial palsy, facial palsy due to CSOM, Post mastoidectomy facial palsies were excluded from study. Patient with known allergy to Botox and patient who lost to follow-up were also excluded from study.Informed consent was taken from all patients in their mother tongue. 
Preparation of BOTOX:
A vial containing 50 IU of Botulinum Toxin A is diluted by 2cc of preservative free distill water. 0.25 cc of injection Botox was drawn in tuberculin syringe which is equal to 6.25 IU. Under all aseptic precautions in MOT patient's eyelid was cleaned by Betadine lotion and covered by sterile drape. Injection 2% Xylocaine 0.5 cc injected sub cutaneously on tarsal plate to anaesthetize the lid and inj. Botox was given at the insertion of LPS on tarsal plate transcutaneously. Treatment of ulcer cornea is continued by giving topical antibiotic eye drops and cycloplegic eye drops. Patient was examined at the end of 1 st week, 2 nd week, 4 th week and 8 th week. At every visit healing of corneal ulcer, height of Palpebral aperture and amount of lagophthalmos was noted.
RESULTS:
At the end of 1 st week in 16 cases mean palpebral aperture height of 9mm (SD +/-1.2mm) before injection of Botox was reduced to 2mm (SD+/- 24 cases of Bell's palsy of whom 11 were males and 13 were females, between the age group of 20 to 80 were selected for study. Male to female percentage ratio was 46/54 in present study which is matching with Adam et al study that had sex percentage ratio of 45.85/54.15 6 . All other study injected Botox at the belly of LPS muscle wherein chances of globe perforation is there. In present study we injected Botox at the insertion of LPS on Tarsal plate, which totally avoided globe perforation.
Median age of presentation in Milind Naik et al study was 30 years. In present study it was 40 years. Reduction in Mean palpebral aperture height of 9mm before injection to 2mm after injection in present study was comparable to Milind naik et al.
Amount of toxin used in present study was 6.25IU which is less when compared to Milind Naik et al who used 12. 5 IU 7 .
